Sulphonylureas are used to manage type 2 diabetes in adults as a phase two or three medicine together with lifestyle management and metformin or other blood sugar-lowering medicines or basal insulin. They can also be used on their own, if metformin or other blood sugar-lowering medicines are not suitable.
In Finland, the use of sulphonylureas tablets has become significantly less common, with new pharmaceutical products becoming available. In Finland (7/2023), there is only one sulphonylurea product in use: glimepiride or, subject to a special permit, glibenclamide.